JEFFREY WEIDEMAN: Open Payments
NPI 1013149079 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 7 payments from 7 companies in 2025. Trend: 2023 $184 · 2024 $125 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $156 |
| LEO Pharma Inc. | 1 | $46 |
| UCB, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Opzelura, Bimzelx, Otezla, Zoryve, DUPIXENT, COSENTYX.
Industry payments across MN — which companies pay providers there.
